Want to join the conversation?
Drugmaker $AGN reported a wider 2Q16 loss as results were impacted by loss of exclusivity on Namenda IR. Net loss widened to $571.3MM or $1.44 per share from $312.7MM or $0.80 per share last year. Revenue grew to $3.68Bil from $3.63Bil, on strong performance in key brands and new product launches. Non-GAAP EPS slid to $3.35 from $3.67.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.